Viewing StudyNCT05511844

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 6:00 PM
Last Modification Date: 2024-10-26 @ 2:40 PM
Study NCT ID: NCT05511844
Status: RECRUITING
Last Update Posted: 2024-04-01
First Post: 2022-08-17
Brief Title: Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors
Sponsor: Orum Therapeutics USA Inc
Organization: Orum Therapeutics USA Inc
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
HER2-positive Breast Cancer
HER-2 Protein Overexpression
HER-2 Gene Amplification
HER2 Gene Mutation
Keywords:
Name View
HER2 Expressing View
HER2 Positive View
HER2 Associated View
Antibody Drug Conjugate View
Protein-Degradation View
GSPT1 View
Celmod View
Imid View